General Information of Drug (ID: DM5DC3R)

Drug Name
1-MNA
Indication
Disease Entry ICD 11 Status REF
Hyperlipidaemia 5C80 Phase 2/3 [1]
Cardiovascular disease BA00-BE2Z Phase 2 [2]
Cross-matching ID
PubChem CID
457
TTD ID
D04EGR
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT00519714) A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)